List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Sustained Release Injectables Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sustained Release Injectables Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sustained Release Injectables Overall Market Size
2.1 Global Sustained Release Injectables Market Size: 2022 VS 2030
2.2 Global Sustained Release Injectables Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sustained Release Injectables Players in Global Market
3.2 Top Global Sustained Release Injectables Companies Ranked by Revenue
3.3 Global Sustained Release Injectables Revenue by Companies
3.4 Top 3 and Top 5 Sustained Release Injectables Companies in Global Market, by Revenue in 2022
3.5 Global Companies Sustained Release Injectables Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sustained Release Injectables Players in Global Market
3.6.1 List of Global Tier 1 Sustained Release Injectables Companies
3.6.2 List of Global Tier 2 and Tier 3 Sustained Release Injectables Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Sustained Release Injectables Market Size Markets, 2022 & 2030
4.1.2 Microparticles
4.1.3 Implants
4.1.4 Gels
4.2 By Type - Global Sustained Release Injectables Revenue & Forecasts
4.2.1 By Type - Global Sustained Release Injectables Revenue, 2018-2023
4.2.2 By Type - Global Sustained Release Injectables Revenue, 2024-2030
4.2.3 By Type - Global Sustained Release Injectables Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sustained Release Injectables Market Size, 2022 & 2030
5.1.2 Diabetes
5.1.3 Leukemia
5.1.4 Acromegaly
5.1.5 Ophthalmology
5.1.6 CNS
5.1.7 Rheumatology
5.1.8 Oncology
5.1.9 Reproductive Health
5.1.10 Others
5.2 By Application - Global Sustained Release Injectables Revenue & Forecasts
5.2.1 By Application - Global Sustained Release Injectables Revenue, 2018-2023
5.2.2 By Application - Global Sustained Release Injectables Revenue, 2024-2030
5.2.3 By Application - Global Sustained Release Injectables Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Sustained Release Injectables Market Size, 2022 & 2030
6.2 By Region - Global Sustained Release Injectables Revenue & Forecasts
6.2.1 By Region - Global Sustained Release Injectables Revenue, 2018-2023
6.2.2 By Region - Global Sustained Release Injectables Revenue, 2024-2030
6.2.3 By Region - Global Sustained Release Injectables Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Sustained Release Injectables Revenue, 2018-2030
6.3.2 US Sustained Release Injectables Market Size, 2018-2030
6.3.3 Canada Sustained Release Injectables Market Size, 2018-2030
6.3.4 Mexico Sustained Release Injectables Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Sustained Release Injectables Revenue, 2018-2030
6.4.2 Germany Sustained Release Injectables Market Size, 2018-2030
6.4.3 France Sustained Release Injectables Market Size, 2018-2030
6.4.4 U.K. Sustained Release Injectables Market Size, 2018-2030
6.4.5 Italy Sustained Release Injectables Market Size, 2018-2030
6.4.6 Russia Sustained Release Injectables Market Size, 2018-2030
6.4.7 Nordic Countries Sustained Release Injectables Market Size, 2018-2030
6.4.8 Benelux Sustained Release Injectables Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Sustained Release Injectables Revenue, 2018-2030
6.5.2 China Sustained Release Injectables Market Size, 2018-2030
6.5.3 Japan Sustained Release Injectables Market Size, 2018-2030
6.5.4 South Korea Sustained Release Injectables Market Size, 2018-2030
6.5.5 Southeast Asia Sustained Release Injectables Market Size, 2018-2030
6.5.6 India Sustained Release Injectables Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Sustained Release Injectables Revenue, 2018-2030
6.6.2 Brazil Sustained Release Injectables Market Size, 2018-2030
6.6.3 Argentina Sustained Release Injectables Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sustained Release Injectables Revenue, 2018-2030
6.7.2 Turkey Sustained Release Injectables Market Size, 2018-2030
6.7.3 Israel Sustained Release Injectables Market Size, 2018-2030
6.7.4 Saudi Arabia Sustained Release Injectables Market Size, 2018-2030
6.7.5 UAE Sustained Release Injectables Market Size, 2018-2030
7 Sustained Release Injectables Companies Profiles
7.1 AntriaBio
7.1.1 AntriaBio Company Summary
7.1.2 AntriaBio Business Overview
7.1.3 AntriaBio Sustained Release Injectables Major Product Offerings
7.1.4 AntriaBio Sustained Release Injectables Revenue in Global Market (2018-2023)
7.1.5 AntriaBio Key News & Latest Developments
7.2 Ascendis Pharma
7.2.1 Ascendis Pharma Company Summary
7.2.2 Ascendis Pharma Business Overview
7.2.3 Ascendis Pharma Sustained Release Injectables Major Product Offerings
7.2.4 Ascendis Pharma Sustained Release Injectables Revenue in Global Market (2018-2023)
7.2.5 Ascendis Pharma Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Sustained Release Injectables Major Product Offerings
7.3.4 AstraZeneca Sustained Release Injectables Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Aurobindo
7.4.1 Aurobindo Company Summary
7.4.2 Aurobindo Business Overview
7.4.3 Aurobindo Sustained Release Injectables Major Product Offerings
7.4.4 Aurobindo Sustained Release Injectables Revenue in Global Market (2018-2023)
7.4.5 Aurobindo Key News & Latest Developments
7.5 Avadel
7.5.1 Avadel Company Summary
7.5.2 Avadel Business Overview
7.5.3 Avadel Sustained Release Injectables Major Product Offerings
7.5.4 Avadel Sustained Release Injectables Revenue in Global Market (2018-2023)
7.5.5 Avadel Key News & Latest Developments
7.6 Alkermes
7.6.1 Alkermes Company Summary
7.6.2 Alkermes Business Overview
7.6.3 Alkermes Sustained Release Injectables Major Product Offerings
7.6.4 Alkermes Sustained Release Injectables Revenue in Global Market (2018-2023)
7.6.5 Alkermes Key News & Latest Developments
7.7 Amylin Pharmaceuticals
7.7.1 Amylin Pharmaceuticals Company Summary
7.7.2 Amylin Pharmaceuticals Business Overview
7.7.3 Amylin Pharmaceuticals Sustained Release Injectables Major Product Offerings
7.7.4 Amylin Pharmaceuticals Sustained Release Injectables Revenue in Global Market (2018-2023)
7.7.5 Amylin Pharmaceuticals Key News & Latest Developments
7.8 Biomarin
7.8.1 Biomarin Company Summary
7.8.2 Biomarin Business Overview
7.8.3 Biomarin Sustained Release Injectables Major Product Offerings
7.8.4 Biomarin Sustained Release Injectables Revenue in Global Market (2018-2023)
7.8.5 Biomarin Key News & Latest Developments
7.9 Camurus
7.9.1 Camurus Company Summary
7.9.2 Camurus Business Overview
7.9.3 Camurus Sustained Release Injectables Major Product Offerings
7.9.4 Camurus Sustained Release Injectables Revenue in Global Market (2018-2023)
7.9.5 Camurus Key News & Latest Developments
7.10 Critical Pharmaceuticals
7.10.1 Critical Pharmaceuticals Company Summary
7.10.2 Critical Pharmaceuticals Business Overview
7.10.3 Critical Pharmaceuticals Sustained Release Injectables Major Product Offerings
7.10.4 Critical Pharmaceuticals Sustained Release Injectables Revenue in Global Market (2018-2023)
7.10.5 Critical Pharmaceuticals Key News & Latest Developments
7.11 Durect
7.11.1 Durect Company Summary
7.11.2 Durect Business Overview
7.11.3 Durect Sustained Release Injectables Major Product Offerings
7.11.4 Durect Sustained Release Injectables Revenue in Global Market (2018-2023)
7.11.5 Durect Key News & Latest Developments
7.12 Eli Lilly
7.12.1 Eli Lilly Company Summary
7.12.2 Eli Lilly Business Overview
7.12.3 Eli Lilly Sustained Release Injectables Major Product Offerings
7.12.4 Eli Lilly Sustained Release Injectables Revenue in Global Market (2018-2023)
7.12.5 Eli Lilly Key News & Latest Developments
7.13 Enzon
7.13.1 Enzon Company Summary
7.13.2 Enzon Business Overview
7.13.3 Enzon Sustained Release Injectables Major Product Offerings
7.13.4 Enzon Sustained Release Injectables Revenue in Global Market (2018-2023)
7.13.5 Enzon Key News & Latest Developments
7.14 Ipsen
7.14.1 Ipsen Company Summary
7.14.2 Ipsen Business Overview
7.14.3 Ipsen Sustained Release Injectables Major Product Offerings
7.14.4 Ipsen Sustained Release Injectables Revenue in Global Market (2018-2023)
7.14.5 Ipsen Key News & Latest Developments
7.15 InnoCore Pharmaceuticals
7.15.1 InnoCore Pharmaceuticals Company Summary
7.15.2 InnoCore Pharmaceuticals Business Overview
7.15.3 InnoCore Pharmaceuticals Sustained Release Injectables Major Product Offerings
7.15.4 InnoCore Pharmaceuticals Sustained Release Injectables Revenue in Global Market (2018-2023)
7.15.5 InnoCore Pharmaceuticals Key News & Latest Developments
7.16 Janssen
7.16.1 Janssen Company Summary
7.16.2 Janssen Business Overview
7.16.3 Janssen Sustained Release Injectables Major Product Offerings
7.16.4 Janssen Sustained Release Injectables Revenue in Global Market (2018-2023)
7.16.5 Janssen Key News & Latest Developments
7.17 Merck
7.17.1 Merck Company Summary
7.17.2 Merck Business Overview
7.17.3 Merck Sustained Release Injectables Major Product Offerings
7.17.4 Merck Sustained Release Injectables Revenue in Global Market (2018-2023)
7.17.5 Merck Key News & Latest Developments
7.18 NanOlogy
7.18.1 NanOlogy Company Summary
7.18.2 NanOlogy Business Overview
7.18.3 NanOlogy Sustained Release Injectables Major Product Offerings
7.18.4 NanOlogy Sustained Release Injectables Revenue in Global Market (2018-2023)
7.18.5 NanOlogy Key News & Latest Developments
7.19 Novartis
7.19.1 Novartis Company Summary
7.19.2 Novartis Business Overview
7.19.3 Novartis Sustained Release Injectables Major Product Offerings
7.19.4 Novartis Sustained Release Injectables Revenue in Global Market (2018-2023)
7.19.5 Novartis Key News & Latest Developments
7.20 Oakwood Laboratories/PharmaSophia
7.20.1 Oakwood Laboratories/PharmaSophia Company Summary
7.20.2 Oakwood Laboratories/PharmaSophia Business Overview
7.20.3 Oakwood Laboratories/PharmaSophia Sustained Release Injectables Major Product Offerings
7.20.4 Oakwood Laboratories/PharmaSophia Sustained Release Injectables Revenue in Global Market (2018-2023)
7.20.5 Oakwood Laboratories/PharmaSophia Key News & Latest Developments
7.21 OctoPlus
7.21.1 OctoPlus Company Summary
7.21.2 OctoPlus Business Overview
7.21.3 OctoPlus Sustained Release Injectables Major Product Offerings
7.21.4 OctoPlus Sustained Release Injectables Revenue in Global Market (2018-2023)
7.21.5 OctoPlus Key News & Latest Developments
7.22 Pacira
7.22.1 Pacira Company Summary
7.22.2 Pacira Business Overview
7.22.3 Pacira Sustained Release Injectables Major Product Offerings
7.22.4 Pacira Sustained Release Injectables Revenue in Global Market (2018-2023)
7.22.5 Pacira Key News & Latest Developments
7.23 PhaseBio Pharmaceuticals
7.23.1 PhaseBio Pharmaceuticals Company Summary
7.23.2 PhaseBio Pharmaceuticals Business Overview
7.23.3 PhaseBio Pharmaceuticals Sustained Release Injectables Major Product Offerings
7.23.4 PhaseBio Pharmaceuticals Sustained Release Injectables Revenue in Global Market (2018-2023)
7.23.5 PhaseBio Pharmaceuticals Key News & Latest Developments
7.24 Recipharm AB
7.24.1 Recipharm AB Company Summary
7.24.2 Recipharm AB Business Overview
7.24.3 Recipharm AB Sustained Release Injectables Major Product Offerings
7.24.4 Recipharm AB Sustained Release Injectables Revenue in Global Market (2018-2023)
7.24.5 Recipharm AB Key News & Latest Developments
7.25 Roche
7.25.1 Roche Company Summary
7.25.2 Roche Business Overview
7.25.3 Roche Sustained Release Injectables Major Product Offerings
7.25.4 Roche Sustained Release Injectables Revenue in Global Market (2018-2023)
7.25.5 Roche Key News & Latest Developments
7.26 Sanofi
7.26.1 Sanofi Company Summary
7.26.2 Sanofi Business Overview
7.26.3 Sanofi Sustained Release Injectables Major Product Offerings
7.26.4 Sanofi Sustained Release Injectables Revenue in Global Market (2018-2023)
7.26.5 Sanofi Key News & Latest Developments
7.27 Taiwan Liposome Company (TLC)
7.27.1 Taiwan Liposome Company (TLC) Company Summary
7.27.2 Taiwan Liposome Company (TLC) Business Overview
7.27.3 Taiwan Liposome Company (TLC) Sustained Release Injectables Major Product Offerings
7.27.4 Taiwan Liposome Company (TLC) Sustained Release Injectables Revenue in Global Market (2018-2023)
7.27.5 Taiwan Liposome Company (TLC) Key News & Latest Developments
7.28 Xbrane Biopharma
7.28.1 Xbrane Biopharma Company Summary
7.28.2 Xbrane Biopharma Business Overview
7.28.3 Xbrane Biopharma Sustained Release Injectables Major Product Offerings
7.28.4 Xbrane Biopharma Sustained Release Injectables Revenue in Global Market (2018-2023)
7.28.5 Xbrane Biopharma Key News & Latest Developments
7.29 Livzon Pharm
7.29.1 Livzon Pharm Company Summary
7.29.2 Livzon Pharm Business Overview
7.29.3 Livzon Pharm Sustained Release Injectables Major Product Offerings
7.29.4 Livzon Pharm Sustained Release Injectables Revenue in Global Market (2018-2023)
7.29.5 Livzon Pharm Key News & Latest Developments
7.30 Luye Pharma Group
7.30.1 Luye Pharma Group Company Summary
7.30.2 Luye Pharma Group Business Overview
7.30.3 Luye Pharma Group Sustained Release Injectables Major Product Offerings
7.30.4 Luye Pharma Group Sustained Release Injectables Revenue in Global Market (2018-2023)
7.30.5 Luye Pharma Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
